Immune Checkpoint Molecules Expressed on CD4(+) T Cell Subsets in Chronic Asymptomatic Hepatitis B Virus Carriers With Hepatitis B e Antigen-Negative.
Immune Checkpoint Molecules Expressed on CD4(+) T Cell Subsets in Chronic Asymptomatic Hepatitis B Virus Carriers With Hepatitis B e Antigen-Negative.
复制标题
乙型肝炎 e 抗原阴性的慢性无症状乙型肝炎病毒携带者 CD4 T 细胞亚群表达的免疫检查点分子
DOI:
10.3389/fmicb.2022.887408
复制
发表时间:
2022
影响因子:
5.2
通讯作者:
中科院分区:
文献类型:
--
作者:
Chronic hepatitis B virus (HBV) infection remains a major public health problem worldwide. Immune checkpoint molecules expressed on CD4+ T cells play critical roles in chronic HBV infection. However, their roles in chronic asymptomatic HBV carriers (ASCs) with hepatitis B e antigen (HBeAg)-negative remain unclear. In this study, we explored the role of immune checkpoint molecules expressed on CD4+ T cell subsets in chronic ASCs with HBeAg-negative. Human peripheral blood mononuclear cells (PBMCs) from the ASCs with HBeAg-negative and healthy controls (HC) were isolated, and immune checkpoint molecules expressed on CD4+ T cell subsets and serum cytokines were detected by flow cytometry. Moreover, the mRNA expressions of immune checkpoint molecules were analyzed by a real-time quantitative PCR assay. In comparison with HC, CD4+ T cells highly expressed LAG-3, TIM-3, and PD-1 in PBMCs from chronic ASCs with HBeAg-negative. Interestingly, the expressions of TIM-3 and PD-1 on circulating follicular helper T (Tfh) cells in ASCs were significantly high. Moreover, high expressions of LAG-3, TIM-3, and PD-1 were different among Treg, Th1, Th2, and Th17 cells. In addition, the expressions of TIM-3 and CTLA-4 mRNA in PBMCs from ASCs were significantly elevated. However, the frequency of CTLA-4+CD4+ T cell subsets in PBMCs from ASCs was not different from HC. The levels of six cytokines in serum from ASCs were not clearly different from HC. Immune checkpoint molecules highly expressed on CD4+ T cell subsets indicated an important role in chronic ASCs with HBeAg-negative, which provided potential therapeutic targets in the pathogenesis of chronic HBV infection.
登录
查看更多内容
影响因子:
5.7
作者:
Dong J;Yang XF;Wang LX;Wei X;Wang AH;Hao CQ;Shen HJ;Huang CX;Zhang Y;Lian JQ
通讯作者:
Lian JQ
影响因子:
6.3
作者:
Liu, Yong;Hu, Xintong;Jiang, Yanfang
通讯作者:
Jiang, Yanfang
影响因子:
25.7
作者:
Bengsch, Bertram;Martin, Bianca;Thimme, Robert
通讯作者:
Thimme, Robert
影响因子:
3.9
作者:
Jin X;Yan ZH;Lu L;Lu S;Zhang G;Lin W
通讯作者:
Lin W
影响因子:
29.4
作者:
Park JJ;Wong DK;Wahed AS;Lee WM;Feld JJ;Terrault N;Khalili M;Sterling RK;Kowdley KV;Bzowej N;Lau DT;Kim WR;Smith C;Carithers RL;Torrey KW;Keith JW;Levine DL;Traum D;Ho S;Valiga ME;Johnson GS;Doo E;Lok AS;Chang KM;Hepatitis B Research Network
通讯作者:
Hepatitis B Research Network